RET-IN-19

Overview

RET-IN-19 (compound 59) is a potent RET inhibitor, with IC 50 values of 6.8 and 13.51 nM against RET-wt and RET V804M , respectively. RET-IN-19 shows anticancer activity. RET-IN-19 can be used for non-small cell lung cancer (NSCLC) research.

Application

Products | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > JAK/STAT Signaling | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > c-Fms | Products > Signaling Pathways > MAP4K | Products > Signaling Pathways > RET | Products > Signaling Pathways > EGFR | Products > Signaling Pathways > Aurora Kinase

Product Information

• Catalog No.: HY-151377
• CAS No.: 2484919-71-1
• Molecular Formula: C28H28N6O4S
• Molecular Weight: 544.62
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source